Pfizer-AstraZeneca takeover rumours prompt job concerns

Astra and Pfizer decline to comment on report that informal discussions have taken place about a possible tie-up

New concerns about the security of jobs in the pharmaceutical sector will be raised this week amid speculation that Pfizer of the US has been in takeover talks with its struggling rival the Anglo-Swedish group AstraZeneca.

A successful acquisition could cost Pfizer up to $ 100bn (£60bn), which would be the biggest ever foreign takeover of a British business. It would raise alarm as the New York City-based group recently closed its main UK research and development facility at Sandwich in Kent with the loss of 2,400 staff.

Continue reading…
Pharmaceuticals industry | The Guardian

Pharmaceutical Stocks


© 2018 Drugs News All rights reserved.       Privacy Policy       Contact Us